All Insights
Coronavirus Legal Briefing | What we're seeing
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.
Coronavirus A guide for your business
COVID-19 – and the measures governments have implemented to slow the spread of the virus – represent an unprecedented challenge
Electronic signatures: COVID-19 and 'business as (un)usual'
As the impact of Covid-19 prompts businesses to rethink and adapt the ways they work, it is more important than
Article 17 of the 'Cura Italia' Decree: semplification of clinical trials for COVID-19 patients
Article 17 of law decree no. 18, dated 17 March 2020, published on even date in the extraordinary edition of
Preliminary remarks on the Italian Government's urgent provisions for COVID-19
Osborne Clarke has prepared a report to help clients dealing with the various legal issues arising from the DPCM 8
Coronavirus | A guide for your business
The coronavirus represents a unique challenge for businesses playing their part in looking after staff and customers, while continuing to
Payback for medical devices: the uncertainty persists
Transparency obligations extended to medical device companies
Transparency obligations for medical device companies (members of Confindustria Dispositivi Medici): transfers of value made during 2020 must be published
The AP imposes its first GDPR fine on a Dutch hospital
Following a lengthy investigation, the Dutch Data Protection Authority (AP) concluded that a Dutch hospital did not take adequate technical
UK Supreme Court gives "skinny label" products (tentative) go ahead – good news for generic pharmaceutical companies and the NHS?
The decision in Warner Lambert v Actavis is good news for generic pharmaceutical companies who will feel emboldened to continue
